Piramal Pharma Ltd.

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue1,0831,0571,5781,1001,391
Expenses987.13967.591,216988.301,115
EBITDA175.24158.64442.83188.39359.27
EBIT124.41107.08390.33136.54305.66
Profit Before Tax96.1989.66362.67111.66275.71
Net Profit77.1674.34273.0885.27210.06
Financial Ratios
Operating Profit Margin17.63%15.49%29.03%17.72%27.97%
Net Profit Margin7.76%7.26%17.90%8.02%16.35%
Earning Per Share (Diluted)0.610.562.060.641.59
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ